Skip to main content

2024 News

2024 News | 2023 News | 2022 Archive | 2021 Archive | 2020 Archive | 2019 Archive | 2018 Archive | 2017 Archive | 2016 Archive


Monday, February 26, 2024

UM School of Medicine Awarded $3.5 Million in Federal Funding to Expand Medical Countermeasures Program

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that UMSOM faculty scientists have been selected as key contractors by the Biomedical Advanced Research and Development Authority (BARDA), for the federal agency’s Radiation Nuclear Animal Model Development program. The $3.5 million award that Erika Davies, PhD, Assistant Professor of Radiation Oncology, received to develop Acute Radiation Syndrome Animal Models, has a $16 million potential total. The Division of Translational Radiation Sciences (DTRS), within the Department of Radiation Oncology, will support this project.


Wednesday, February 21, 2024

UMSOM and UMB Faculty Receive $10.6 Million in State Funding for Abortion Clinical Care Training Program

A $10.6 million training grant has been awarded to the University of Maryland School of Medicine (UMSOM) and University of Maryland, Baltimore (UMB) to administer Maryland’s Abortion Clinical Care Training Program. The grant will be used to expand the number of healthcare professionals with abortion care training, increase the racial and ethnic diversity among health care professionals with abortion care education, and support the identification of clinical sites needing training.


Tuesday, February 20, 2024

Leading Technology Investment Executive Troy LeMaile-Stovall Appointed to University of Maryland School of Medicine Board of Visitors

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, along with UMSOM Board of Visitors Chair Cynthia Egan, announced today that Troy LeMaile-Stovall, an award-winning technology investment, higher education, and management consulting executive has been appointed to the Schools’ Board of Visitors.


Wednesday, January 31, 2024

Large Multicenter Clinical Trial Finds that Antiseptic Containing Iodine Reduces Surgical-Site Infections in Patients with Extremity Fractures

A large multicenter clinical trial co-led by University of Maryland School of Medicine researchers found that an antiseptic containing iodine resulted in about one-quarter fewer post-surgical infections in patients with limb fractures compared to another frequently used skin antiseptic. The results of the study of nearly 8,500 patients across the United States and Canada were published today in the New England Journal of Medicine.


Wednesday, January 31, 2024

Renowned Surgeon Dr. Bartley Griffith Named Vice Chair for Innovation in UM School of Medicine’s Department of Surgery

University of Maryland School of Medicine (UMSOM) Department of Surgery Chair Christine Lau, MD, MBA, along with UMSOM Dean Mark T. Gladwin, MD, announced today the appointment of Bartley P. Griffith, MD, as the Department of Surgery’s first Vice Chair for Innovation. In this role, Dr. Griffith will nurture a culture of innovation, entrepreneurship, and collaboration in the Department, and expand the integration of related sciences into surgical practice. The appointment is effective on February 1.


Thursday, January 25, 2024

Single Dose Typhoid Conjugate Vaccine (TCV) Provides Lasting Efficacy in Children

A single dose of the typhoid conjugate vaccine, Typbar TCV, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study conducted by researchers at University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health (CVD) and led by in-country partners at the Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme.


Wednesday, January 03, 2024

Senior Academic Development Leader Lindsay Farrington, MBA, Named New Vice President of Development at University of Maryland Medicine

University of Maryland Medical Center (UMMC) President and CEO, Bert W. O'Malley, MD, along with University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Lindsay Farrington, MBA, a leader in advancement operations for academic and healthcare institutions, will become Vice President of Development at University of Maryland Medicine Philanthropy, the joint advancement operation of the UMMC and UMSOM. Ms. Farrington will report to Heather Culp, Senior Vice President, Chief Philanthropy Officer and Senior Associate Dean. Her appointment began on December 29.


Wednesday, January 03, 2024

Sanford Stass, MD, Longtime Chair of the Department of Pathology and the Department of Medical & Research Technology, to Step Down

Sanford A. Stass, MD, Professor and Chair of the Department of Pathology and the Department of Medical & Research Technology at the University of Maryland School of Medicine (UM SOM), announced today that he will be stepping down from his longtime role as Chair of the two departments. He will continue as a full-time member of the faculty of the Department of Pathology and the Department of Medical & Research Technology.